Shares of Swiss medical holding company Sonova (SOON.CH) are declining nearly 8% and slipping below key support as the company announced the loss of a major U.S. customer, which could hit its financial results in at least the first half of the year. Also Q1 results were mixed. However, Sonova didn't disclose the name of given US company:
- Analysts at JP Morgan, Jefferies and Vontobel indicated that the frm that Sonova does not want to disclose is one of the largest US wholesalers Costco (COST.US). Sonova's management conveyed in a statement that results were solid but not enough to dampen market sentiment;
- Pre-tax profit was CHF 840.4 million in Q1 2023, which beat analysts' forecast of CHF 859.7 million in a Vara Research survey. At the same time, however, Q1 sales rose 14.6%, below expectations of 15%-19%, suggesting that inflation is curbing demand for the company's equipment and services;
- Sonova said, however, that it still expects consolidated sales to grow 3%-7% in 2023-2024, and adjusted pre-tax profit excluding currency factors to rise in the 6%-10% range,
- In an interview with Reuteres, a Sonova spokesman indicated that the loss of a U.S. trading partner will be a hurdle in the first half of the year. The company is keeping a close eye on consumer trends in a challenging economic environment;
- The commentary on the results also read that full-year profit will likely be below expectations, and that it may take longer to return to the pace of robust growth given the loss of a customer in the US and inflation. This information did not please investors. If the loss of the Costco contract is confirmed - it could cost the company a significant reduction in revenue from the US market.
Sonova (SOON.CH) shares, W1 interval. The stock price was at January 2020 levels, just before the Covidian meltdown that hit demand for its services and products. The stock has settled below the SMA200 (red line) signaling that a test of trend strength around the 61.8 and 71.6 Fibonacci restracement is still possible. If the support set by the 2020 price reaction does not hold, a test of CHF240 per share will become realistic. Source: xStation5.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
